{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:44:13Z","timestamp":1771512253985,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12880-018-0254-8","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T10:47:41Z","timestamp":1525862861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Quantification of FDG-PET\/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-9200","authenticated-orcid":false,"given":"Christina","family":"Baun","sequence":"first","affiliation":[]},{"given":"Kirsten","family":"Falch","sequence":"additional","affiliation":[]},{"given":"Oke","family":"Gerke","sequence":"additional","affiliation":[]},{"given":"Jeanette","family":"Hansen","sequence":"additional","affiliation":[]},{"given":"Tram","family":"Nguyen","sequence":"additional","affiliation":[]},{"given":"Abass","family":"Alavi","sequence":"additional","affiliation":[]},{"given":"Poul-Flemming","family":"H\u00f8ilund-Carlsen","sequence":"additional","affiliation":[]},{"given":"Malene G.","family":"Hildebrandt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"issue":"2","key":"254_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"254_CR2","unstructured":"International Agency for Research on Cancer, Globocan 2012. \n                    http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx\n                    \n                  . Accessed 11 May 2016."},{"issue":"2","key":"254_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.12110853","volume":"266","author":"D Groheux","year":"2013","unstructured":"Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET\/CT in the clinical management of breast cancer. Radiology. 2013;266(2):388\u2013405.","journal-title":"Radiology"},{"issue":"50","key":"254_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14500","volume":"14","author":"M Pennant","year":"2010","unstructured":"Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, Eisinga A, Andronis L, Arvanitis T, Deeks J, Hyde C. A systematic review of positron emission tomography (PET) and positron emission tomography\/computed tomography (PET\/CT) for the diagnosis of breast cancer recurrence. Health Technol Asses. 2010;14(50):1\u2013103.","journal-title":"Health Technol Asses"},{"issue":"1","key":"254_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiographics.22.1.g02ja055","volume":"22","author":"WB Eubank","year":"2002","unstructured":"Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, Lindsley SK, Gralow JR, Austin-Seymour MM, Ellis GK, et al. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics. 2002;22(1):5\u201317.","journal-title":"Radiographics"},{"issue":"5","key":"254_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00259-013-2343-9","volume":"40","author":"G Cheng","year":"2013","unstructured":"Cheng G, Torigian DA, Zhuang H, Alavi A. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol I. 2013;40(5):779\u201387.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"7","key":"254_CR7","first-page":"871","volume":"43","author":"A Matthies","year":"2002","unstructured":"Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43(7):871\u20135.","journal-title":"J Nucl Med"},{"issue":"1","key":"254_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cpet.2015.07.003","volume":"11","author":"S Houshmand","year":"2016","unstructured":"Houshmand S, Salavati A, Segtnan EA, Grupe P, Hoilund-Carlsen PF, Alavi A. Dual-time-point imaging and delayed-time-point Fluorodeoxyglucose-PET\/computed tomography imaging in various clinical settings. PET Clin. 2016;11(1):65\u201384.","journal-title":"PET Clin"},{"issue":"3","key":"254_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11307-012-0600-0","volume":"15","author":"G Cheng","year":"2013","unstructured":"Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15(3):345\u201352.","journal-title":"Mol Imaging Biol"},{"issue":"Suppl 2","key":"254_CR10","doi-asserted-by":"publisher","first-page":"24s","DOI":"10.2967\/jnumed.107.047258","volume":"49","author":"RJ Gillies","year":"2008","unstructured":"Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med. 2008;49(Suppl 2):24s\u201342s.","journal-title":"J Nucl Med"},{"issue":"3","key":"254_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s002590050381","volume":"26","author":"AR Boerner","year":"1999","unstructured":"Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, Bender HG, Mueller-Gaertner HW. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med. 1999;26(3):226\u201330.","journal-title":"Eur J Nucl Med"},{"issue":"11","key":"254_CR12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2967\/jnumed.111.093716","volume":"46","author":"R Kumar","year":"2005","unstructured":"Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med. 2005;46(11):1819\u201324.","journal-title":"J Nucl Med"},{"issue":"9","key":"254_CR13","first-page":"1440","volume":"47","author":"A Mavi","year":"2006","unstructured":"Mavi A, Urhan M, Yu JQ, Zhuang H, Houseni M, Cermik TF, Thiruvenkatasamy D, Czerniecki B, Schnall M, Alavi A. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med. 2006;47(9):1440\u20136.","journal-title":"J Nucl Med"},{"issue":"7","key":"254_CR14","first-page":"1044","volume":"44","author":"S Beaulieu","year":"2003","unstructured":"Beaulieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, Pham P, Lewellen B, Mankoff DA. SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med. 2003;44(7):1044\u201350.","journal-title":"J Nucl Med"},{"issue":"1","key":"254_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11307-007-0121-4","volume":"10","author":"S Basu","year":"2008","unstructured":"Basu S, Mavi A, Cermik T, Houseni M, Alavi A. Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology? Mol Imaging Biol. 2008;10(1):62\u20136.","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"254_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1754-9485.2011.02287.x","volume":"55","author":"WL Chan","year":"2011","unstructured":"Chan WL, Ramsay SC, Szeto ER, Freund J, Pohlen JM, Tarlinton LC, Young A, Hickey A, Dura R. Dual-time-point (18)F-FDG-PET\/CT imaging in the assessment of suspected malignancy. J Med Imag Radiat On. 2011;55(4):379\u201390.","journal-title":"J Med Imag Radiat On"},{"issue":"3","key":"254_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11307-010-0394-x","volume":"13","author":"JW Lee","year":"2011","unstructured":"Lee JW, Kim SK, Lee SM, Moon SH, Kim TS. Detection of hepatic metastases using dual-time-point FDG PET\/CT scans in patients with colorectal cancer. Mol Imaging Biol. 2011;13(3):565\u201372.","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"254_CR18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00259-007-0467-5","volume":"34","author":"S Basu","year":"2007","unstructured":"Basu S, Alavi A. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? Eur J Nucl Med Mol I. 2007;34(10):1527\u20139.","journal-title":"Eur J Nucl Med Mol I."},{"issue":"2","key":"254_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10549-013-2687-7","volume":"141","author":"T Kadoya","year":"2013","unstructured":"Kadoya T, Aogi K, Kiyoto S, Masumoto N, Sugawara Y, Okada M. Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography\/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study. Breast Cancer Res Tr. 2013;141(2):269\u201375.","journal-title":"Breast Cancer Res Tr"},{"issue":"7","key":"254_CR20","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1007\/s00259-009-1306-7","volume":"37","author":"D Vriens","year":"2010","unstructured":"Vriens D, Visser EP, de Geus-Oei LF, Oyen WJ. Methodological considerations in quantification of oncological FDG PET studies. Eur J Nucl Med Mol I. 2010;37(7):1408\u201325.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"2","key":"254_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cpet.2013.10.003","volume":"9","author":"C Gamez-Cenzano","year":"2014","unstructured":"Gamez-Cenzano C, Pino-Sorroche F. Standardization and quantification in FDG-PET\/CT imaging for staging and restaging of malignant disease. PET Clin. 2014;9(2):117\u201327.","journal-title":"PET Clin."},{"issue":"3","key":"254_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.semnuclmed.2007.01.005","volume":"37","author":"S Basu","year":"2007","unstructured":"Basu S, Zaidi H, Houseni M, Bural G, Udupa J, Acton P, Torigian DA, Alavi A. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Semin Nucl Med. 2007;37(3):223\u201339.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"254_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","volume":"38","author":"D Groheux","year":"2011","unstructured":"Groheux D, Giacchetti S, Moretti JL, Porcher R, Espie M, Lehmann-Che J, de Roquancourt A, Hamy AS, Cuvier C, Vercellino L, et al. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol I. 2011;38(3):426\u201335.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"22","key":"254_CR24","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1002\/cncr.27579","volume":"118","author":"PG Morris","year":"2012","unstructured":"Morris PG, Ulaner GA, Eaton A, Fazio M, Jhaveri K, Patil S, Evangelista L, Park JY, Serna-Tamayo C, Howard J, et al. Standardized uptake value by positron emission tomography\/computed tomography as a prognostic variable in metastatic breast cancer. Cancer. 2012;118(22):5454\u201362.","journal-title":"Cancer"},{"issue":"9","key":"254_CR25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s00259-013-2418-7","volume":"40","author":"AM Garcia Vicente","year":"2013","unstructured":"Garcia Vicente AM, Soriano Castrejon A, Leon Martin A, Chacon Lopez-Muniz I, Munoz Madero V. Munoz Sanchez Mdel M, Palomar Munoz a, Espinosa Aunion R, Gonzalez Ageitos a: molecular subtypes of breast cancer: metabolic correlation with (1)(8)F-FDG PET\/CT. Eur J Nucl Med Mol I. 2013;40(9):1304\u201311.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"6","key":"254_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2967\/jnumed.106.035774","volume":"48","author":"M Soret","year":"2007","unstructured":"Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48(6):932\u201345.","journal-title":"J Nucl Med"},{"issue":"9","key":"254_CR27","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00259-010-1472-7","volume":"37","author":"NJ Hoetjes","year":"2010","unstructured":"Hoetjes NJ, van Velden FH, Hoekstra OS, Hoekstra CJ, Krak NC, Lammertsma AA, Boellaard R. Partial volume correction strategies for quantitative FDG PET in oncology. Eur J Nucl Med Mol I. 2010;37(9):1679\u201387.","journal-title":"Eur J Nucl Med Mol I."},{"issue":"4","key":"254_CR28","first-page":"424","volume":"58","author":"F Gallivanone","year":"2014","unstructured":"Gallivanone F, Canevari C, Sassi I, Zuber V, Marassi A, Gianolli L, Picchio M, Messa C, Gilardi MC, Castiglioni I. Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer. Q J Nucl Med. 2014;58(4):424\u201339.","journal-title":"Q J Nucl Med"},{"issue":"8","key":"254_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/00004647-200208000-00014","volume":"22","author":"JA Aston","year":"2002","unstructured":"Aston JA, Cunningham VJ, Asselin MC, Hammers A, Evans AC, Gunn RN. Positron emission tomography partial volume correction: estimation and algorithms. J Cerebr Blood F Met. 2002;22(8):1019\u201334.","journal-title":"J Cerebr Blood F Met"},{"issue":"7","key":"254_CR30","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1088\/0031-9155\/51\/7\/016","volume":"51","author":"N Boussion","year":"2006","unstructured":"Boussion N, Hatt M, Lamare F, Bizais Y, Turzo A, Cheze-Le Rest C, Visvikis D. A multiresolution image based approach for correction of partial volume effects in emission tomography. Phys Med Biol. 2006;51(7):1857\u201376.","journal-title":"Phys Med Biol"},{"issue":"1","key":"254_CR31","first-page":"8","volume":"14","author":"DA Torigian","year":"2011","unstructured":"Torigian DA, Lopez RF, Alapati S, Bodapati G, Hofheinz F, van den Hoff J, Saboury B, Alavi A. Feasibility and performance of novel software to quantify metabolically active volumes and 3D partial volume corrected SUV and metabolic volumetric products of spinal bone marrow metastases on 18F-FDG-PET\/CT. Hell J Nuc Med. 2011;14(1):8\u201314.","journal-title":"Hell J Nuc Med"},{"issue":"1","key":"254_CR32","first-page":"16","volume":"2","author":"F Hofheinz","year":"2012","unstructured":"Hofheinz F, Langner J, Petr J, Beuthien-Baumann B, Oehme L, Steinbach J, Kotzerke J, van den Hoff J. A method for model-free partial volume correction in oncological PET. Eur J Nucl Med Mol I Research. 2012;2(1):16.","journal-title":"Eur J Nucl Med Mol I Research"},{"key":"254_CR33","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1200\/JCO.2015.63.5185","volume":"34","author":"MG Hildebrandt","year":"2016","unstructured":"Hildebrandt MG, Gerke O, Baun C, Falch K, Hansen JA, Farahani ZA, Petersen H, Larsen LB, Duvnjak S, Buskevica I, et al. [18F]Fluorodeoxyglucose (FDG)-positron emission tomography (PET)\/computed tomography (CT) in suspected recurrent breast Cancer: a prospective comparative study of dual-time-point FDG-PET\/CT, contrast-enhanced CT, and bone scintigraphy. J Clin Oncol. 2016;34:1889\u201397.","journal-title":"J Clin Oncol"},{"issue":"1","key":"254_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3413\/Nukmed-0419-11-07","volume":"51","author":"F Hofheinz","year":"2012","unstructured":"Hofheinz F, Potzsch C, Oehme L, Beuthien-Baumann B, Steinbach J, Kotzerke J, van den Hoff J. Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin. 2012;51(1):9\u201316.","journal-title":"Nuklearmedizin"},{"issue":"4","key":"254_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12149-009-0261-5","volume":"23","author":"K Suga","year":"2009","unstructured":"Suga K, Kawakami Y, Hiyama A, Matsunaga N. Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET\/CT scan. Ann Nucl Med. 2009;23(4):399\u2013407.","journal-title":"Ann Nucl Med"},{"key":"254_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11547-009-0491-6","volume":"115","author":"MG Caprio","year":"2010","unstructured":"Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martino G, Farina A, Avitabile G, Pace L, Forestieri P, Salvatore M. Dual-time-point [18F]-FDG PET\/CT in the diagnostic evaluation of suspicious breast lesions. Radiol Med. 2010;115:215\u201324.","journal-title":"Radiol Med"},{"issue":"1003","key":"254_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1259\/bjr\/56324742","volume":"84","author":"WH Choi","year":"2011","unstructured":"Choi WH, Yoo IR, JH O, Kim SH, Chung SK. The value of dual-time-point 18F-FDG PET\/CT for identifying axillary lymph node metastasis in breast cancer patients. Brit J Rad. 2011;84(1003):593\u20139.","journal-title":"Brit J Rad"},{"issue":"1","key":"254_CR38","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/RLU.0000000000000446","volume":"40","author":"A Chirindel","year":"2015","unstructured":"Chirindel A, Alluri KC, Tahari AK, Chaudhry M, Wahl RL, Lodge MA, Subramaniam RM. Liver standardized uptake value corrected for lean body mass at FDG PET\/CT: effect of FDG uptake time. Clin Nucl Med. 2015;40(1):e17\u201322.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"254_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00256-008-0643-0","volume":"38","author":"R Tian","year":"2009","unstructured":"Tian R, Su M, Tian Y, Li F, Li L, Kuang A, Zeng J. Dual-time point PET\/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skelet Radiol. 2009;38(5):451\u20138.","journal-title":"Skelet Radiol"},{"issue":"14","key":"254_CR40","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","volume":"22","author":"T Hamaoka","year":"2004","unstructured":"Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22(14):2942\u201353.","journal-title":"J Clin Oncol"},{"issue":"10","key":"254_CR41","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","volume":"16","author":"GJ Cook","year":"1998","unstructured":"Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16(10):3375\u20139.","journal-title":"J Clin Oncol"},{"issue":"9","key":"254_CR42","first-page":"1519","volume":"45","author":"R Boellaard","year":"2004","unstructured":"Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45(9):1519\u201327.","journal-title":"J Nucl Med"},{"issue":"7","key":"254_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0969-8051(00)00155-4","volume":"27","author":"SC Huang","year":"2000","unstructured":"Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol. 2000;27(7):643\u20136.","journal-title":"Nucl Med Biol"},{"issue":"10","key":"254_CR44","first-page":"1836","volume":"36","author":"JW Keyes Jr","year":"1995","unstructured":"Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36(10):1836\u20139.","journal-title":"J Nucl Med"},{"issue":"3","key":"254_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00259-004-1566-1","volume":"32","author":"NC Krak","year":"2005","unstructured":"Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol I. 2005;32(3):294\u2013301.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"11","key":"254_CR46","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2967\/jnumed.108.054239","volume":"49","author":"C Nahmias","year":"2008","unstructured":"Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med. 2008;49(11):1804\u20138.","journal-title":"J Nucl Med"},{"issue":"10","key":"254_CR47","doi-asserted-by":"publisher","first-page":"787","DOI":"10.7150\/thno.5629","volume":"3","author":"B Bai","year":"2013","unstructured":"Bai B, Bading J, Conti PS. Tumor quantification in clinical positron emission tomography. Theranostics. 2013;3(10):787\u2013801.","journal-title":"Theranostics"},{"issue":"Suppl 1","key":"254_CR48","doi-asserted-by":"publisher","first-page":"11s","DOI":"10.2967\/jnumed.108.057182","volume":"50","author":"R Boellaard","year":"2009","unstructured":"Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(Suppl 1):11s\u201320s.","journal-title":"J Nucl Med"},{"issue":"2","key":"254_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11307-011-0514-2","volume":"14","author":"G Tomasi","year":"2012","unstructured":"Tomasi G, Turkheimer F, Aboagye E. Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future. Mol Imaging Biol. 2012;14(2):131\u201346.","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"254_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cpet.2014.09.004","volume":"10","author":"S Houshmand","year":"2015","unstructured":"Houshmand S, Salavati A, Hess S, Werner TJ, Alavi A, Zaidi H. An update on novel quantitative techniques in the context of evolving whole-body PET imaging. PET Clin. 2015;10(1):45\u201358.","journal-title":"PET Clin."},{"issue":"2","key":"254_CR51","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol I. 2015;42(2):328\u201354.","journal-title":"Eur J Nucl Med Mol I"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-018-0254-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12880-018-0254-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-018-0254-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:05:25Z","timestamp":1557342325000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-018-0254-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1186\/s12880-018-0254-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"11 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in compliance with good clinical practice and the Declaration of Helsinki and written informed consent was obtained from all included patients. The study where approved by the Science Ethics Committees for the Capital Region of Denmark (protocol number: S-20110138), and registered at ClinicalTrails.gov (NCT01552655).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"11"}}